DIO Corporation (KOSDAQ:039840)
South Korea · Delayed Price · Currency is KRW 17,500
+280 (1.63%)
Sep 12, 2025, 3:30 PM KST
DIO Corporation Market Cap
DIO Corporation has a market cap or net worth of 239.12 billion as of September 12, 2025. Its market cap has increased by 4.00% in one year.
Market Cap
239.12B
Enterprise Value
272.13B
Revenue
145.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,500.00
Market Cap Chart
Since March 1, 2001, DIO Corporation's market cap has increased from 25.42B to 239.12B, an increase of 840.60%. That is a compound annual growth rate of 9.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 239.12B | 7.08% |
| Dec 30, 2024 | 223.31B | -31.36% |
| Dec 28, 2023 | 325.35B | 11.83% |
| Dec 29, 2022 | 290.93B | -47.39% |
| Dec 30, 2021 | 553.05B | 17.94% |
| Dec 30, 2020 | 468.91B | -25.34% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.88T |
| Celltrion | 37.82T |
| ALTEOGEN | 26.27T |
| Yuhan | 8,955.07B |
| SK Biopharmaceuticals | 8,692.77B |
| Peptron | 7,152.29B |
| PharmaResearch | 6,690.93B |
| ABL Bio | 5,746.76B |